Abstract:1297 Objectives The standard uptake value (SUV) of 18F-FDG PET/CT is important in the diagnosis and treatment response evaluation of lung cancer. The aim of the present study is to investigate the clinical value of SUV of 99mTc-3PRGD2 SPECT/CT in lung cancer diagnosis. Methods Twenty-four patients with pathologically approved lung cancer (21 non-small cell lung cancer and 3 small cell lung cancer),4 patients with benign diseases (3 pulmonary consolidation and 1 adenoma), and 6 healthy volunteers were enrolled in the study. All subjects were injected with 629.0-921.3 MBq of 99mTc-3PRGD2 (mean ± SD, 759.3 ± 80.1 MBq), and a SPECT/CT (Discovery NM/CT 670, GE Healthcare) was performed 30 minutes later. The images were analyzed using Q.Metrix (GE Healthcare) after OSEM reconstruction with resolution recovery technology, scatter correction and Xray CT based attenuation correction. The mean SUV (SUVmean) and the maximum SUV (SUVmax) of the superior, middle, and inferior mediastinum and the right lower lobe of the liver in healthy volunteers, as well as the corresponding values of the primary lesions in the patients, were measured with a 3 cm-diameter volume of interest (VOI). The longest diameters of the primary lesions in CT images of the patients were measured as well. Results The median age of the lung cancer patients, benign disease patients and healthy volunteers was 60.5 (43-76) years old, 62.0 (52-76) years old and 56.0 (44-64) respectively. Fourteen of the 24 lung cancer patients (58.3%), 2 of the 4 benign disease patients (50%) and 3 of the 6 healthy volunteers (50%) were male. The mean value of the SUVmean and the SUVmax of the superior, middle, and inferior mediastinum were 0.64 ± 0.27 g/ml and 1.06 ± 0.41 g/ml. The SUVmean and the SUVmax of the right lower lobe of the liver in healthy volunteers were 1.85 ± 0.72 g/ml and 2.35 ± 0.92 g/ml. The longest diameter of the primary lesion in CT images in the 24 lung cancer patients was 3.68 ± 2.02 cm; the corresponding SUVmean and SUVmax values were 1.67 ± 1.04 g/ml and 3.68 ± 2.12 g/ml. In the 4 benign lesions, the longest diameter in CT images was 2.60 ± 0.45 cm, and the SUVmean and SUVmax were 0.64 ± 0.27 g/ml and 0.96 ± 0.36 g/ml, respectively. The diagnostic sensitivity, specificity and accuracy of SUVmean and SUVmax of 99mTc-3PRGD2 in lung carcinoma verses the mean + 2SD of mediastinum were 0.67, 1.00, 0.71 and 0.67, 1.00, 0.71, respectively. Conclusions (1) The mean + 2SD of the SUV mean and SUVmax of mediastinum seems a valid threshold for 99mTc-3PRGD2 SPECT/CT in lung carcinoma diagnosis; (2) SUV of 99mTc-3PRGD2 SPECT/CT, as an indicator of lung cancer, is in good compliance and accordance with pathological diagnosis. The SUV of 99mTc-3PRGD2 SPECT/CT is a promising tool in the diagnosis and differential diagnosis of lung cancer. RESEARCH SUPPORT: This work was financially supported, in part, by the National Natural Science Foundation of China (NSFC) projects (Grant No.81071188, 81571713 and 81171369) and Beijing Municipal Science & Technology Commission (Grant No.Z151100003915133)

Evaluation of 99Tcm-3Prgd2 Integrin Receptor Imaging in Qualitative Diagnosis of Breast Cancer and Its Comparison with Mammography

Evaluation of Tc-99m-3prgd2 Integrin Receptor Imaging in the Differential Diagnosis of Breast Lesions and Comparison with Mammography

Differential Diagnosis of Imaging Fmdings Between Patients with Triple-Negative Breast Cancer and Patients with Idiopathic Granulomatous Mastitis

Integrin Receptor Imaging of Breast Cancer Using 99Mtc-3Prgd2 SPECT/CT: Compared with 18F-FDG PET/CT

An Exploratory Study on 99Mtc-Rgd-bbn Peptide Scintimammography in the Assessment of Breast Malignant Lesions Compared to 99Mtc-3P4-rgd2.

(99m)Tc-3PRGD2 Scintimammography in Palpable and Nonpalpable Breast Lesions.

Integrin Receptor Imaging 99Mtc-3Prgd2 SPECT/CT in Diagnosis and Lymph Node Staging of Non-Small Cell Lung Cancer

Comparison of 99Mtc-3Prgd2 Integrin Receptor Imaging with 99Mtc-Mdp Bone Scan in Diagnosis of Bone Metastasis in Patients with Lung Cancer: a Multicenter Study.

Evaluation of Standard Uptake Value of 99Mtc-3Prgd2 Spect/Ct in Lung Cancer Diagnosis

99Mtc-3Prgd2 for Integrin Receptor Imaging of Lung Cancer: A Multicenter Study

Comparison of [99mtc]3prgd2 Imaging and [18F]FDG PET/CT in Breast Cancer and Expression of Integrin Αvβ3 in Breast Cancer Vascular Endothelial Cells

Integrin Imaging with 99Mtc-3Prgd2 SPECT/CT Shows High Specificity in the Diagnosis of Lymph Node Metastasis from Non-Small Cell Lung Cancer.

Comparison Between 99Mtc-Methoxyisobutyl Isonitrile and 99Mtc-Methylenediphosphonate Scintimammography for Detection Ofbreast Carcino Ma

Clinical value of 18F-FDG PET/CT in combination with mammography and ultrasound in diagnosis of breast cancer

99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.

99Mtc-Glu-c(rgdyk)-bombesin SPECT Can Reduce Unnecessary Biopsy of Masses That Are BI-RADS Category 4 on Ultrasonography

[Qualitative and quantitative PET/MRI in the evaluation of axillary lymph node metastasis in patients with breast cancer].

Comparison of 99Tcm-rituximab planar and SPECT/CT lymphoscintigraphy for sentinel lymph nodes of breast cancer

Retrospective and comparative analysis of 99m Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women

The Usefulness of Technetium-99m-Mibi Scintimammography in Diagnosis of Breast Cancer: Using Surgical Histopathologic Diagnosis As the Gold Standard

Visual and Semi-Quantitative Analyses of Dual-Phase Breast-Specific Gamma Imaging with Tc-99m-sestamibi in Detecting Primary Breast Cancer.